NASDAQ Composite opens in less than one hour and Amicus Therapeutics‘s pre-market value is already 7.72% up.
The last session, NASDAQ Composite ended with Amicus Therapeutics sliding 1.3% to $9.84. NASDAQ Composite dropped 0.85% to $13,962.68, following the last session’s downward trend on what was a somewhat negative trend trading session.
Amicus Therapeutics’s last close was $9.97, 158.03% under its 52-week high of $25.39.
Amicus Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 27.6%, now sitting on 260.89M for the twelve trailing months.
Amicus Therapeutics’s last day, last week, and last month’s current volatility was 2.61%, 1.36%, and 2.06%, respectively.
Amicus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.92% (day), 3.28% (last week), and 3.99% (last month), respectively.
More news about Amicus Therapeutics.